Literature DB >> 25624720

NOB1 is essential for the survival of RKO colorectal cancer cells.

Xiao-Wen He1, Tao Feng1, Qiao-Ling Yin1, Yuan-Wei Jian1, Ting Liu1.   

Abstract

AIM: To determine the role of NOB1, a regulator of cell survival in yeast, in human colorectal cancer cells.
METHODS: Lentivirus-mediated small interfering RNA (siRNA) was used to inhibit NOB1 expression in RKO human colorectal cancer cells in vitro and in vivo in a mouse xenograft model. The in vitro and in vivo knockdown efficacy was determined using both Western blot and quantitative reverse transcription polymerase chain reaction (qRT-PCR). qRT-PCR was also used to analyze the downstream signals following NOB1 knockdown. Cell growth and colony formation assays were used to determine the effect of NOB1 inhibition on RKO proliferation and their ability to form colonies. Endonuclease activity, as evaluated by terminal deoxytransferase-mediated dUTP nick end labeling (TUNEL), and annexin V staining were used to determine the presence of apoptotic cell death prior to and following NOB1 inhibition. Cell cycle analysis was used to determine the effect of NOB1 inhibition on RKO cell cycle. A cDNA microarray was used to determine global differential gene expression following NOB1 knockdown.
RESULTS: Virus-mediated siRNA inhibition of NOB1 resulted in (1) the down-regulation of NOB1 expression in RKO cells for both the mRNA and protein; (2) inhibition of NOB1 expression both in vitro and in vivo experimental systems; (3) cell growth inhibition via significant induction of cell apoptosis, without alteration of the cell cycle distribution; and (4) a significant decrease in the average weight and volume of xenograft tumors in the NOB1-siRNA group compared to the control scr-siRNA group (P = 0.001, P < 0.05). Significantly more apoptosis was detected within tumors in the NOB1-siRNA group than in the control group. Microarray analysis detected 2336 genes potentially regulated by NOB1. Most of these genes are associated with the WNT, cell proliferation, apoptosis, fibroblast growth factor, and angiogenesis signaling pathways, of which BAX and WNT were validated by qRT-PCR. Among them, 1451 probes, representing 963 unique genes, were upregulated; however, 2308 probes, representing 1373 unique genes, were downregulated.
CONCLUSION: NOB1 gene silencing by lentivirus-mediated RNA interference can inhibit tumor growth by inducing apoptosis of cancerous human colorectal cells.

Entities:  

Keywords:  Apoptosis; BAX; Colorectal cancer; NOB1; Small RNA interference; WNT

Mesh:

Substances:

Year:  2015        PMID: 25624720      PMCID: PMC4299339          DOI: 10.3748/wjg.v21.i3.868

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

1.  DAVID: Database for Annotation, Visualization, and Integrated Discovery.

Authors:  Glynn Dennis; Brad T Sherman; Douglas A Hosack; Jun Yang; Wei Gao; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-04-03       Impact factor: 13.583

2.  PIN domain of Nob1p is required for D-site cleavage in 20S pre-rRNA.

Authors:  Alessandro Fatica; David Tollervey; Mensur Dlakić
Journal:  RNA       Date:  2004-09-23       Impact factor: 4.942

Review 3.  Molecular movement inside the translational engine.

Authors:  K S Wilson; H F Noller
Journal:  Cell       Date:  1998-02-06       Impact factor: 41.582

Review 4.  New insights into proteasome function: from archaebacteria to drug development.

Authors:  A L Goldberg; R Stein; J Adams
Journal:  Chem Biol       Date:  1995-08

5.  Diverse molecular provocation of programmed cell death.

Authors:  I E Wertz; M R Hanley
Journal:  Trends Biochem Sci       Date:  1996-10       Impact factor: 13.807

6.  Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity.

Authors:  Z J Chen; L Parent; T Maniatis
Journal:  Cell       Date:  1996-03-22       Impact factor: 41.582

7.  Cyclin is degraded by the ubiquitin pathway.

Authors:  M Glotzer; A W Murray; M W Kirschner
Journal:  Nature       Date:  1991-01-10       Impact factor: 49.962

Review 8.  A matter of life and death.

Authors:  Douglas R Green; Gerard I Evan
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

Review 9.  The proteasome as a target for cancer therapy.

Authors:  Peter M Voorhees; E Claire Dees; Bert O'Neil; Robert Z Orlowski
Journal:  Clin Cancer Res       Date:  2003-12-15       Impact factor: 12.531

10.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

Authors:  M Pagano; S W Tam; A M Theodoras; P Beer-Romero; G Del Sal; V Chau; P R Yew; G F Draetta; M Rolfe
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

View more
  9 in total

1.  Overexpression of microRNA-107 suppressed proliferation, migration, invasion, and the PI3K/Akt signaling pathway and induced apoptosis by targeting Nin one binding (NOB1) protein in a hypopharyngeal squamous cell carcinoma cell line (FaDu).

Authors:  Xin Gao; Xinlong Fan; Wei Zeng; Jiwang Liang; Nan Guo; Xiao Yang; Yuejiao Zhao
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

2.  Effects of NOB1 on the pathogenesis of osteosarcoma and its expression on the chemosensitivity to cisplatin.

Authors:  Leiming Luo; Yuanhui Wang; Yiran Yin; Jianhua Ge; Xiaobo Lu
Journal:  Oncol Lett       Date:  2018-01-04       Impact factor: 2.967

3.  Screening for implicated genes in colorectal cancer using whole‑genome gene expression profiling.

Authors:  Long-Ci Sun; Hai-Xin Qian
Journal:  Mol Med Rep       Date:  2018-04-11       Impact factor: 2.952

4.  MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.

Authors:  Yongtao Zhang; Fang Wang; Lina Wang; Quanbin Zhang
Journal:  World J Surg Oncol       Date:  2020-05-01       Impact factor: 2.754

5.  miR-326 Inhibits Gastric Cancer Cell Growth Through Downregulating NOB1.

Authors:  Sheqing Ji; Bin Zhang; Ye Kong; Fei Ma; Yawei Hua
Journal:  Oncol Res       Date:  2016-10-11       Impact factor: 5.574

6.  Ribosome assembly factor PNO1 is associated with progression and promotes tumorigenesis in triple‑negative breast cancer.

Authors:  Jie Li; Liya Liu; Youqin Chen; Meizhu Wu; Xiaoying Lin; Zhiqing Shen; Ying Cheng; Xiaoping Chen; Nathaniel Weygant; Xiangyan Wu; Lihui Wei; Thomas J Sferra; Yuying Han; Xi Chen; Aling Shen; Aling Shen; Jun Peng
Journal:  Oncol Rep       Date:  2022-04-21       Impact factor: 3.906

7.  Low-level miR-646 in colorectal cancer inhibits cell proliferation and migration by targeting NOB1 expression.

Authors:  Huajia Dai; Kezhu Hou; Zujin Cai; Qi Zhou; Song Zhu
Journal:  Oncol Lett       Date:  2017-09-22       Impact factor: 2.967

8.  Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma.

Authors:  Jiandong Wang; Lei Cao; Jianhong Wu; Qiugen Wang
Journal:  Int J Oncol       Date:  2017-11-03       Impact factor: 5.650

9.  High expression of eukaryotic initiation factor 3M predicts poor prognosis in colon adenocarcinoma patients.

Authors:  Qing-Hua Wang; Min Zhang; Ming-Hui Zhou; Xiao-Jiao Gao; Fang Chen; Xun Yan; Feng Lu
Journal:  Oncol Lett       Date:  2019-11-29       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.